# Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

> **NCT00003968** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 35 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** bryostatin 1

## Key facts

- **NCT ID:** NCT00003968
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2003-12
- **Final completion:** —
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003968, "Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*